Mounjaro® reimbursement prices redetermined for September 2025
Following a decision taken by Eli Lilly to increase its UK list prices for Mounjaro® (Tirzepatide) KwikPen® from 1 September 2025, the Department of Health and Social Care (DHSC) has re-determined the NHS reimbursement prices for all strengths of Mounjaro® dispensed from September to reflect the new, higher list prices.
To avoid pharmacy owners dispensing Mounjaro® (Tirzepatide) at a loss, Community Pharmacy England reached an agreement with DHSC that reimbursement of NHS prescriptions (branded and generically written) for Mounjaro® dispensed from September will be reimbursed at the increased UK list prices.
Please see the link to the announcement published on NHSBSA’s website.
Please note: the redetermined reimbursement prices will apply to September prescriptions even though the September 2025 Drug Tariff still shows the old list prices. The new list prices will be updated in the October 2025 Drug Tariff.
The re-determined Mounjaro® (Tirzepatide) reimbursement prices from September are outlined in the table below:
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined NHS reimbursement price from September 2025 |
| Tirzepatide 2.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Mounjaro® KwikPen® 2.5mg/0.6ml solution for injection 2.4ml pre-filled pens | 1 pre-filled disposable injection | £92.00 | £133.00 |
| Tirzepatide 5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Mounjaro® KwikPen® 5mg/0.6ml solution for injection 2.4ml pre-filled pens | 1 pre-filled disposable injection | £92.00 | £180.00 |
| Tirzepatide 7.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Mounjaro® KwikPen® 7.5mg/0.6ml solution for injection 2.4ml pre-filled pens | 1 pre-filled disposable injection | £107.00 | £255.00 |
| Tirzepatide 10mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Mounjaro® KwikPen® 10mg/0.6ml solution for injection 2.4ml pre-filled pens | 1 pre-filled disposable injection | £107.00 | £255.00 |
| Tirzepatide 12.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices | Mounjaro® KwikPen® 12.5mg/0.6ml solution for injection 2.4ml pre-filled pens | 1 pre-filled disposable injection | £122.00 | £330.00 |
| Tirzepatide 15mg/0.6ml solution for injection 2.4ml pre-filled disposable devices |
Mounjaro® KwikPen® 15mg/0.6ml solution for injection 2.4ml pre-filled pens
|
1 pre-filled disposable injection | £122.00 | £330.00 |
Background to Mounjaro® list price increases
Following a review, Lilly will increase the UK list price for Mounjaro® (Tirzepatide) from 1st September to address pricing inconsistencies compared to other developed countries, including in Europe. In parallel, Lilly has reached an agreement with the NHS to ensure continued supply and patient access. While Lilly does not determine the prices that private healthcare providers set, Lilly is working with them to maintain patient access.
Please note: Community Pharmacy England understands there are growing concerns regarding Mounjaro® pricing and supply arrangements for private services offered by many pharmacies. However, Community Pharmacy England’s remit is restricted to NHS pharmacy services and we are therefore unable to address queries relating to the private supply of Mounjaro®.
To maintain patient access to Mounjaro®, Lilly has a commercial agreement available to all private providers to support the dispensing of private prescriptions. Pharmacies that do not dispense private prescriptions for Mounjaro® are advised not to accept the commercial agreement. Pharmacies that choose not to sign up to the commercial agreement can continue to access stock of Mounjaro® for NHS dispensing in the usual way.
